Recombinant human growth hormone (rhGH) treatment of infants and young children with chronic renal failure
Maxwell, H.
British Journal of Clinical Practice. Supplement 85: 64-65
1996
ISSN/ISBN: 0262-8767 PMID: 8995037 Document Number: 456329
Infants with chronic renal failure often grow badly despite medical management. rhGH treatment results in good catch-up growth and should be used in infants who do not respond to conservative management.
Document emailed within 1 workday
Related Documents
Fine, R.N.; Koch, V.H.; Boechat, M.I.; Lippe, B.H.; Nelson, P.A.; Fine, S.E.; Sherman, B.M. 1990: Recombinant human growth hormone (rhGH) treatment of children undergoing peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 10(3): 209-214Szynaka, E.; Petriczko, E.żb.; Grabarek, J.; Miklaszewicz, A.; Domagala, W.; Walczak, M. 2010: Effects of recombinant human growth hormone (rhGH) replacement therapy on detailed immunologic parameters in somatotropine--deficient paediatrics patients prior and after 6 months of rhGH treatment Neuro Endocrinology Letters 31(4): 553-558
Greco, M.; Cappa, M.; Perruzza, I.; Rizzoni, G. 1996: Can provocative growth hormone testing predict the response to recombinant human growth hormone (rhGH) treatment? British Journal of Clinical Practice. Suppl 85: 38-40
Ito, K.; Kawaguchi, H.; Shizume, K.; Hibi, I. 1995: The effects of recombinant human growth hormone (r-hGH, SM-9500, genotropin) on growth failure in children with uremia. Japanese Multi-Center Study (Genotropin) Group on Children with Renal Disease Nihon Jinzo Gakkai Shi 37(3): 186-193
Rees, L. 1996: The role of recombinant human growth hormone (rhGH) in pubertal patients British Journal of Clinical Practice. Suppl 85: 14-17
Fine, R.N. 1996: Recombinant human growth hormone in children with chronic renal insufficiency--clinical update: 1995 Kidney International. Supplement 53: S115-S118
Kuo, H.F.; Liu, P.C.; Shih, K.C.; Lee, T.S.; Ho, L.T. 1992: Recombinant human growth hormone (Genotropin) in treatment of children with growth hormone deficiency: the first year observation Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi Zhonghua Minguo Xiao Er Ke Yi Xue Hui 33(1): 12-19
Jeevanandam, M.; Begay, C.K.; Shahbazian, L.M.; Petersen, S.R. 2000: Altered plasma cytokines and total glutathione levels in parenterally fed critically ill trauma patients with adjuvant recombinant human growth hormone (rhGH) therapy Critical Care Medicine 28(2): 324-329
Touati, G.; Ruiz, J.C.; Porquet, D.; Kindermans, C.; Prieur, A.M.; Czernichow, P. 2000: Effects on bone metabolism of one year recombinant human growth hormone administration to children with juvenile chronic arthritis undergoing chronic steroid therapy Journal of Rheumatology 27(5): 1287-1293
Shih, K.C.; Ho, L.T.; Kuo, H.F.; Chang, T.C.; Liu, P.C.; Chen, C.K.; Tiu, C.M. 1994: Linear growth response to recombinant human growth hormone in children with growth hormone deficiency Zhonghua Yi Xue Za Zhi 54(1): 7-13
Tuchinda, C.; Angsusingha, K.; Likitmaskul, S.; Chaichanwatanakul, K.; Unachak, K.; Patarakijvanich, N.; Thongphiew, A. 1990: Effect of recombinant DNA human growth hormone in Thai children with growth hormone deficiency Journal of the Medical Association of Thailand 73(7): 371-374
Jiang, J.; Wang, W.; Sun, W-xin.; Wang, X-min.; Ni, J-hong.; Chen, F-sheng.; Wang, D-fen. 2004: Effects of China-made recombinant human growth hormone on the treatment of growth hormone deficiency Chinese Medical Sciences Journal 19(3): 225-229
Ksiazek, A.; Baranowska-Daca, E. 1993: Hematocrit influence on peritoneal dialysis effectiveness during recombinant human erythropoietin treatment in patients with chronic renal failure Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 13(Suppl 2): S550-S552
Swanepoel, C.R.; Moosa, M.R.; Rowland, G.F.; Meyers, A.M.; Botha, B.P.; Smart, A.J.; Goodman, R.; Schall, R.; Keogh, H.J.; Merrifield, E.H. 1996: Clinical experience with Repotin, a locally produced recombinant human erythropoietin, in the treatment of anaemia of chronic renal failure in South Africa South African Medical Journal 86(10): 1266-1269
Kulzer, P.; Schaefer, R.M.; Krahn, R.; Schaefer, L.; Heidland, A. 1994: Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. European Multicentre Study Group International Journal of Artificial Organs 17(4): 195-202
Finkenstedt, G.; Höfle, G.; Pallua, A.; Sailer, U.; Gasser, R.W. 1999: Changes in the volume of residual pituitary adenomas in patients with adult-onset growth hormone deficiency during replacement therapy with the recombinant human growth hormone Wiener Klinische Wochenschrift 111(21): 887-890
Ahangari, G.; Ostadali, M.R.; Rabani, A.; Rashidian, J.; Sanati, M.H.; Zarindast, M.R. 2004: Growth hormone antibodies formation in patients treated with recombinant human growth hormone International Journal of Immunopathology and Pharmacology 17(1): 33-38
Kopple, J.D.; Brunori, G.; Leiserowitz, M.; Mattimore, C.; Hirschberg, R. 1991: Growth hormone treatment for patients with renal failure Nihon Jinzo Gakkai Shi 33(5): 468-474
Hotta, T.; Ogawa, H.; Saito, A.; Ito, A. 1991: Iron balance following recombinant human erythropoietin therapy for anemia associated with chronic renal failure International Journal of Hematology 54(3): 195-200
Howrie, D.L. 1987: Growth hormone for the treatment of growth failure in children Clinical Pharmacy 6(4): 283-291